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Recent experiments have identified interactions between presynaptic and synaptic vesicle membrane proteins, that might be important in organizing 
the components of the fast neurotransmitter r lease mechanism to ensure that the process follows a rapid time course. Here we extend previous 
investigations to show that in addition to the ~-latrotoxin receptor (neurexin) and synaptotagmin a other presynaptic protein, syntaxin, co-purifies 
on a ~-latrotoxin affinity column. This implies that syntaxin is associated with these two molecules in a complex; a conclusion supported by the 
immunoprecipitation of [t25I]latrotoxin binding by syntaxin antibodies. In addition, antibodies against syntaxin and the ~-latrotoxin receptor 
immunoprecipitate [~25I]c0-conotoxin bi ding sites, indicating that calcium channels are associated with this complex. Thus, neurexin, synaptotag- 
min, syntaxin, and calcium channels can be found in a structure we propose to call the 'synaptosecretosome'. The components of the synaptose- 
cretosome, in association with additional proteins, are postulated to organize the process of neurotransmitter r lease. 
~-Latrotoxin; Neurexin; Synaptotagmin; Syntaxin; Ca 2+ channel; Synaptosecretosome 
1. INTRODUCTION 
Fast neurotransmitters a e released within 200/Is of 
presynaptic stimulation, suggesting that the molecular 
components that underlie this specialized stimulation/ 
secretion coupling are highly organized [1]. This suppo- 
sition has an ultrastructural correlate in the active zone. 
Here, the small synaptic vesicles (ssvs), the storage and 
release organelles of the neuron's fast transmitters, are 
clustered at specialized regions of the presynaptic mem- 
brane [2]. Proteins from both vesicle and other presyn- 
aptic compartments are thought o participate in this 
clustering and ensure the organized arrangement that 
enables rapid release. Initial studies focussed on the role 
of the synapsins, sv-associated proteins which by virtue 
of their phosphorylation-dependent affinity for both 
ssvs and cytoskeletal e ements have been implicated in 
vesicle mobilization [3]. Recent experiments also indi- 
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cate that interactions exist between ssvs and presynaptic 
membrane proteins which might play an important role 
in vesicle-plasma membrane association. 
The demonstration that the ssv protein synapto- 
physin binds to the presynaptic plasma membrane pro- 
tein physophilin provided the first indication that pro- 
tein/protein interactions might exist between the two 
membrane compartments hat fuse during transmitter 
release [4]. More recently, another ssv protein synapto- 
tagmin has been shown to bind directly to the cc-Ltx 
receptor [5], a presynaptic protein of unknown physio- 
logical function which represents the target site of the 
presynaptically acting ~-Ltx [6,7]. The interaction with 
synaptotagmin is mediated by the intracellular C-termi- 
nus of the c~-Ltx receptor and the related neurexins, 
which are predicted from cDNA to constitute a highly 
polymorphic family of proteins [8,9]. It has also recently 
been shown that synaptotagmin, along with several 
other molecularly characterized ssv proteins, can exist 
as a multimeric omplex [10]. This complex includes a 
previously uncharacterized presynaptic membrane pro- 
tein which was subsequently cloned and called syntaxin 
[11]. Both syntaxin and synaptotagmin have also been 
identified as the epitopes for a series of independently 
produced antibodies that efficiently immunoprecipitate 
the calcium channels that bind o)-Ctx [ 11,12,13,14,15]. 
These c0-Ctx-sensitive channels are thought at least in 
part, to be responsible for the calcium influx that trig- 
gers transmitter release [16]. In this study we extend this 
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line of  invest igat ion and show that syntaxin is associ- 
ated with the 0~-Ltx receptor /synaptotagmin  complex. 
We also provide evidence that these three proteins asso- 
ciate in a complex with the calc ium channel .  The very 
recent not ion  that syntaxin may be a neurona l  receptor 
involved in the targeting of  fus ion-competent  ssvs to 
active zones [17] indicates that this mult imer ic  protein 
complex,  which we propose to term 'synaptosecre-  
tosome' ,  may be fundamenta l  in adapt ing an ub iqu i tous  
fusion mechan ism into one suited to the requi rements  
of  point  to point  communicat ion  i  the nervous system. 
2. MATERIALS  AND METHODS 
2.1. o~-Ltx purification, iodination and affinity-column synthesis 
~-Ltx was purified from lyophilized Central Asia Black Widow 
spider venom as described previously [18]. Purified toxin (200 pmol) 
was labelled with ~25I (Amersham) using the lactoperoxidase method 
under conditions described elsewhere for nerve growth factor [19]. 
This yielded [~:Sl]~-Ltx with a specific activity of 2500~,400 Ci/mmol. 
~-Ltx-Sepharose was prepared by reacting the toxin with CNBr- 
Sepharose (0.3 0.5/tg/ml matrix) under conditions recommended by
the manufacturer (Pharmacia). 
2.2. Purification of the o~-Ltx receptor 
Crude rat brain membranes were prepared and solubilized in Triton 
X-100 as described previously for bovine brain [20]. Prior to loading 
onto the ~-Ltx column (1 /J1), the solubilized extract was diluted to 
reduce the Triton X-100 concentration to 0.5% (w/v). The column was 
exhaustively washed with 200 column volumes of Tris-buffer (20 mM 
Tris-HC1, pH 7.7) containing 2.5 mM CaC12, 130 mM KCI, 0.1% (w/v) 
Triton and 0.3 mM PMSF. The columns were subsequently eluted by 
either Tris buffer containg 1M KC1/10 mM EDTA/0. ! % (w/v) Lubrol- 
PX or, sequentially, by first a 0.13 0.6 M KC1 gradient in Tris-buffer 
that contained 2.5 mM CaCIJ0.1% (w/v) Lubrol-PX followed by the 
I M KCI buffer used above. Fractions of 1.5 ml were collected at 
selected points of the load and washing and throughout the elution 
profiles. Initial experiments u ed the solubilized ~-Ltx receptor bind- 
ing assay [20] to detect he receptor eluted from the column. 
2.3. Sucrose gradient centrifugation 
The initial fraction from a one step elution of the ~-Ltx affinity 
column was dialyzed overnight against 800 volumes of Tris-buffer 
containing 200 mM KCI, 2.5 mM CaCIz. 0.1% (w/v) Triton X-100 and 
0.3 mM PMSF. Aliquots (500/11) were loaded onto a 11.2/J1 5 20% 
(w/v) sucrose gradient over a 0.3 #1 50% (w/v) sucrose cushion. All 
sucrose mixtures were prepared in Tris-buffer that contained 200 mM 
KC1, 2 mM CaC12 and 0.1% (w/v) Triton X-100. The gradients were 
centrifuged at 33,000 rpm in a SW-41 Beckman rotor at 4°C for 
16 h and divided into 17 fractions of equal volume. Parallel gradients 
were used to determine the position of marker proteins as described 
previously [4]. 
2.4. Gel eh, etrophoresis and Western blotting 
Protein samples from receptor purification and sucrose gradients 
were concentrated byTCA precipitation [21] and subjected to SDS- 
PAGE on 5-18% linear gradient gels according to Laemmli [22]. Gels 
were either silver-stained [23] or transferred to nitrocellulose accord- 
ing to the method of Burnette [24]. The nitrocellulose was divided into 
three strips that contained peptides of apparent molecular weight > 97 
kDa, those between 97 and 45 kDa, and those < 45 kDa, and probed 
with antibodies generated against he C-terminal of neurexins I, a 
fusion protein of synaptotagmin [25], and syntaxin [14], respectively. 
Immunoreactivity was detected using horseradish peroxidase-coupled 
secondary antibody in combination with the ECL detection system 
(Amersham). 
2.5. Generation of neurexin-specific antibodies 
Antisera were raised in New Zealand White rabbits against he 
synthetic peptide CAKSANKNKKNKDKEYYV (Nrx-1) which ex- 
cluding the N-terminal cysteine corresponds tothe extreme C-terminal 
of both the 1~ and lfl neurexins as predicted from their cDNA se- 
quences [8]. The peptide was coupled to keyhole limpet haemocyanin 
through the N-terminal cysteine [26]. After one boost, the sera gave 
a specific response against the neurexins detected in purified fractions, 
as determined by peptide competition. These sera and subsequent 
bleeds were affinity-purified on a Nrx-1 peptide column before use 
[26]. 
2.6. lmmunoprecipitation of [J2:l]a-Ltx and [:esI]o-Ctx receptors 
Protein A-Sepharose (Pharmacia) was washed and incubated with 
antibodies as described [10] although the buffers used varied to ensure 
conditions optimized in each case for [~25I]~-Ltx [20] or [~25I]oJ-Ctx 
binding [14]. Solubilized crude brain membranes quivalent tothe load 
material or purified receptor dialysed overnight as described above, 
were incubated with [~zsI]~-Ltx for 4 h at 4°C. To assess immunopre- 
cipitation of [~25I]~o-Ctx binding, membranes were prelabelled prior to 
solubilization i Triton X-100 essentially as described previously [t3]. 
The labelled fractions were incubated with the antibod~protein A 
Sepharose conjugate overnight. The Sepharose was pelleted, washed 
3 times, and the pellets were counted for radioactivity. 
3. RESULTS AND DISCUSSION 
Aff inity pur i f icat ion on a ~-Ltx co lumn of  crude 
bra in  membrane  xtracts has been reported to result in 
specific [~25I]:z-Ltx b ind ing  fract ions conta in ing  a series 
of  polypept ides with the fol lowing apparent  molecular  
weights, 200-160, 120, 79, 65, 43, 36 and 29 kDa 
[5,20,27]. Here, a similar pur i f icat ion protocol  led to the 
e lut ion of  specific [125I-~]Ltx b ind ing  sites and a similar 
complex polypept ide pattern (Fig. 1). The major  bands  
at 200 160, 120, 72, 65 and 45 kDa (Fig. la) p robab ly  
cor respond to previously described bands,  and  minor  
differences in apparent  molecular  weight relate to the 
different gel condi t ions  used. The bands  at 72 and 45 
kDa are likely to represent the ub iqu i tous  proteins 
which can be purif ied f rom tissues that lack [LzsI-~]Ltx 
b ind ing  sites and are retained on  the co lumn by a direct 
interact ion with the immobi l ized toxin [27]. The band 
at 120 kDa has been described as ~-Ltx leaching f rom 
the co lumn [5,27], and  we have conf i rmed this by im- 
munob lo t t ing  with toxin-specif ic sera (result not  
shown). The group of  proteins runn ing  at 160-200 kDa 
represent he components  of  the eluted fract ions that 
b ind  ~-Ltx and have been identif ied as members  of  the 
neurex in  family [7,20,27]. Us ing an ant ibody  generated 
against  he C- terminus  of  neurexin 1 we conf i rmed that 
the high molecu lar  weight bands  in our  preparat ion  are 
neurexins (Fig. l b). Similarly, immunob lo t t ing  identi-  
fied the band at 65 kDa as the ssv protein synaptotag-  
min.  Synaptotagmin  has been shown to interact with the 
cytoplasmic C- termina l  tail of  neurexins [9]. Thus,  the 
co-pur i f icat ion of  synaptotagmin  on the co lumn is due 
to an interact ion with the neurex in  isoform that repre- 
sents the cz-Ltx receptor [9]. Among the series of  bands  
in the eluate that ran at approx imate ly  35-38 kDa [5,27] 
we identif ied syntaxin,  a molecule of  presynapt ic  or igin 
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co-migrated on the gradient. In contrast, syntaxin mi- 
grated as a distinct peak of immunoreactivity, indicat- 
ing that its association with the synaptotagmin/neurexin 
complex implied by its co-purification on the c~-Ltx col- 
umn was not recovered after dialysis. 
Independent evidence for an association of neurexin, 
synaptotagmin, and syntaxin in a macromolecular com- 
plex was derived from immunoprecipitat ion experi- 
ments (Table I). [12sI]~-Ltx was incubated with purified 
receptor (dialysed against low salt and Ca 2+) or solubil- 
ized crude rat brain extract.  These extracts were equiv- 
alent to those loaded onto the ~-Ltx column, from 
which neurexin, synaptotagmin a d syntaxin co-purify, 
and thus should contain these molecules in a complex. 
The Nrx-1 ant ibody efficiently precipitated specifically 
bound toxin from both purified receptor preparations 
and solubilized extracts. Control  experiments showed 
that this immunoprecipitat ion f [~25I]c~-Ltx binding 
sites was prevented by preincubation with excess unla- 
belled toxin; moreover, none of the antibodies used di- 
rectly precipitated [~25I]~-Ltx (data not shown). The 
syntaxin ant ibody (mAb 10D2; 14) was able to precipi- 
tate specific binding sites from solubilized extracts, but 
not purified receptor fractions. This observation further 
supports the view that syntaxin is complexed with the 
Fig. 1. Synaptotagmin a d syntaxin copurify with neurexin on an 
affinity column. Solubilized rat brain membranes prepared from 15 g 
of brain tissue were loaded onto an c~-Ltx column, which was subse- 
quently eluted in one step. Fractions of 1.5 ml were collected, concen- 
trated by TCA-precipitation a d resuspended in 100 pl sample buffer. 
Fractions were run on parallel 5 18% gradient gels which were either 
silver stained (a) or transferred tonitrocellulose for immunobloning 
(b) with neurexin (Nrx-1, 4 pg/ml), syntaxin (mAb 6D2, 1:1000) or 
synaptotagmin (Syn, 1:10,000) antibodies. Load (L), flowthrough (F), 
and fractions from the beginning, middle and end of the 200 ml wash 
are shown in addition to the eluted fractions. The position of molecu- 
lar weight markers is shown on the left. Arrowheads mark the posi- 
tions of neurexin, synaptotagmin a d syntaxin. 
Table I
Immunoprecipitation of [~25I]c~-Ltx and [t25I]co-Ctx binding sites from 
membrane extracts and purified c~-Ltx receptor preparations 
Antibody 
Sites precipitated 
[125I]~-LTX [~ 25I]-co-CTX 
Receptor Extract Extract 
NRX-1 1250 + 39* 614 + 15 763 + 12 
Synaptotagmin 23 + 1 35 + 1 140 + 5 
Syntaxin (mAbl0D2) 17 + 1 254 + 25 4004 _+ 33 
that has been shown to interact with synaptotagmin. 
The syntaxin detected in the eluted fractions co-distrib- 
uted with neurexin and synaptotagmin, i dicating that 
formation of a complex between these molecules causes 
their co-purification. However, only a minority of the 
solubilized syntaxin loaded onto the column is retained 
within this complex. In contrast o the above, we were 
unable to detect either the ssv protein synaptophysin or
its presynaptic partner protein, physophil in [4], in the 
eluted fractions (data not shown). 
To further characterize the interaction between syn- 
aptotagmin, syntaxin, and neurexin, the c~-Ltx column 
eluate was subjected to sucrose gradient centrifugation 
after extensive dialysis to remove EDTA and salts po- 
tentially interfering with neurexin/synaptotagmin 
[5,20,27] and synaptotagmin/syntaxin [11] interactions. 
Analysis of the gradient fractions (Fig. 2) showed that 
For precipitation f[~-'sI]c~-Ltx binding sites, the antibodies (250 pg or 
* 15/,tg) were incubated with 12.5 pl of protein A-Sepharose. Dialysed 
receptor or detergent extracts were incubated with [~25I]~-Ltx (0.24).5 
nM) for 4 h at 4°C. 200pl of these incubations containing 250,000 cpm 
were added to the antibody protein A-Sepharose conjugates. After 
overnight incubation and 3 washes, the bound radioactivity was meas- 
ured. Crude brain membranes resuspended in 20 mM Tris-HC1, pH 
8.0, 2 mM EDTA, were prelabelled with 0.3 nM [~25I]o9- Ctx for 4 h 
at 4°C (> 90% of the counts bound under these conditions could be 
blocked if labelling was performed inthe presence ofexcess unlabelled 
toxin). The labelled binding sites were solubilized in 1% (w/v) Triton 
X-100, before this was diluted to 0.5% in a Tris/EDTA buffer contain- 
ing 400 mM NaC1. 400/11 of this fraction containing 30,000 cpm were 
incubated overnight with 10/11 aliquots Protein A Sepharose preab- 
sorbed with 120 pg of the antibodies. These incubations were pelleted 
and washed 3 times before counting bound radioactivity. Values are 
the mean of duplicate or triplicate stimates determined in parallel and 
are expressed as % of the radioactivity precipitated by Protein A- 
Sepharose coated with an equivalent amount of preimmune lgG. 
Other experiments u ing separate membrane and iodinated toxin 
preparations gave similar esults. 
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Fig. 2. Sucrose gradient centrifugation f affinity-purified ~-Ltx receptor fractions. The first two fractions from a one step eluted c~-Ltx column 
were pooled and dialysed before loading onto a sucrose gradient. The gradient was divided into l 7 fractions which were TCA precipitated, issolved 
in 40 ¢tl sample buffer and subjected to PAGE on a 5 18% gradient gel. A TCA precipitated fraction of the purified receptor representing 1/3 of 
the fraction loaded onto the sucrose gradient was also analyzed (R). After transfer to nitrocellulose, strips were cut and immunoblotted with 
neurexin, synaptotamin or syntaxin antibodies as described in Fig. 1. Fraction l marks the bottom of the gradient. The position of marker enzymes 
measured in identically prepared gradients, run in parallel, were: fl-galactosidase (fraction 3), catalase (fraction 5), lactate dehydrogenase (fraction 
9), malate dehydrogenase (fraction 12) and cytochrome c (fraction 15). 
~-Ltx receptor, but  this interact ion is irreversibly dis- 
rupted by the high salt used to elute the co lumn.  Rela- 
tively high syntaxin ant ibody  concentrat ions  were re- 
quired to precipitate [~sI]c~-Ltx binding.  This is consis- 
tent with only a fract ion of  the solubi l ized syntaxin 
being complexed under  the condi t ions used. Under  
none of  the condi t ions  tested were we able to im- 
munoprec ip i ta te  o~-Ltx b ind ing  with the synaptotagmin  
ant ibodies  a l though this has been succesfully done using 
different synaptotagmin  ant ibodies [9]. Thus,  either the 
ant ibodies used in this study do not  recognize nat ive rat 
synaptotagmin ,  or the epitopes which they recognize are 
masked by prote in/prote in  i teract ions.  
Two of  the components  identif ied in the complex de- 
scribed above, namely  synaptotagmin  and syntaxin,  
have also been shown to associate with co-Ctx b ind ing  
1 2 3 4 5 6 7 8 9 10111213 
kDa 
205 
116 
97 
66 
45 
29 
4 
NRX 
SYN 
mAb 6D2 
Fig. 3. Two-step elution of the ~-Ltx affinity column. Membranes from 15 g of rat brains were solubilized and loaded onto the column, which 
was washed as described in section 2. The column was eluted with a gradient of KC1 (0.134/.6 M) containing 2.5 mM CaCI2 and 0.1% (w/v) 
Lubrol-PX in Tris-buffer, (fractions 1-8). After washing with the 0.6 M KC1 containing buffer (fractions 8, 9), the column was subjected to further 
elution with Tris/PMSF buffer containing 10 mM EDTA and 1 M KCI (fractions 11 13). Aliquots (1 ml) of the collected 1.5 ml fractions were 
concentrated byTCA precipitation and divided into two portions for analysis on 5 18% gradient gels. Two gels run in parallel were either silver 
stained (a) or transferred tonitrocellulose for immunoblotting (b)with antibodies against the neurexins (Nrx-1), synaptotagmin (Syn) or syntaxin 
(mAb-6D2). 
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Fig. 4. Model of the interactions between presynaptic proteins of the synaptosecretosome. The components of the complex shown in black include 
the ~-Ltx receptor (neurexin), synaptotagmin, syntaxin and the w-conotoxin binding Ca 2+ channel. Accordingly, we propose that binding of 
neurexin and syntaxin is mediated by synaptotagmin. The exact organization of the ternary complex depicted is likely oversimplified asboth 
synaptotagmin a d syntaxin have been proposed to exist as tetrameric structures [14,28]. Also shown is the ubiquitous 20S fusion complex 
containing NSF/SNAPs that is thought to contribute to the specificity of vesicl~plasma embrane interaction through binding to syntaxin and 
synaptobrevin, which act as the receptors for this complex in the presynaptic plasma nd ssv membranes, respectively [17]. 
sites, i.e presynaptic Ca 2+ channels [11-15]. This 
prompted us to investigate using immunoprecipitation 
whether neurexin could be found in a complex with 
w-Ctx binding sites. In agreement with previous tudies 
[14], the syntaxin antibody efficiently precipitated (o- 
Ctx binding sites from solubilized extracts. In addition, 
neurexin antibodies were able to precipitate a smaller 
but clearly significant portion of the co-Ctx binding. 
This indicates that at least some Ca > channels are com- 
plexed with neurexin. 
These data suggest hat neurexin, synaptotagmin a d 
syntaxin are organized in a complex that is associated 
with the Ca 2+ channel. As indicated above both the 
synaptotagmin/neurexin and the synaptotagmin/syn- 
taxin interaction are disrupted by high salt concentra- 
tions [5,11,20,27]; therefore we eluted an ~-Ltx column 
loaded with crude rat brain extract with a gradient of 
increasing KC1 concentration i  the presence of Ca 2+ 
before applying elution with a high salt/EDTA buffer. 
Apart from the neurexins the other proteins associated 
with the column began to elute at early stages of the salt 
gradient (Fig. 3a). The slightly earlier elution of synap- 
totagmin as compared to the 72 and 45 kDa proteins is 
consistent with previous results. Although the peak of 
neurexin was eluted by high salt/EDTA, some of the 
neurexin protein was found in the fractions of the salt 
gradient. This prevented the complete separation of 
neurexin and synaptotagmin that has been described 
previously using such a 2-step elution [5,27]. Protein 
bands of a molecular weight corresponding to syntaxin, 
while stained poorly with silver, co-eluted with synapto- 
tagmin. This result was confirmed by immunoblotting, 
which shows that the peak syntaxin and synaptotagmin 
immunoreactivities lute together. This data does not 
rule out a direct interaction between syntaxin and neur- 
exin, but along with previous results (see section 1) leads 
us to conclude that a proportion of neurexin, synapto- 
tagmin, syntaxin and the c0-Ctx binding sites, by se- 
quential associations, lie within a ternary complex, 
which we propose to call the 'synaptosecretosome' (Fig.4). 
Syntaxin has recently been implicated as a receptor 
for fusion competent ssvs [17]. Vesicle binding has been 
proposed to involve the ssv protein synaptobrevin and 
the fusion complex which contains NSF and SNAP 
proteins [17]. In this regard it is interesting to note that 
synaptobrevin immunoreactivity was not found in the 
syntaxin containing fractions that eluted from the ~-Ltx 
column. However, we cannot exclude the possibility 
that the minor bands at approximately 36 kDa contain 
SNAP proteins, which have been shown to co-migrate 
with syntaxin on SDS-polyacrylamide g ls [17]. 
In conclusion, this study extends the notion that com- 
ponents of the presynaptic plasma and ssv membranes 
can exist as a complex.Within this complex, the synap- 
tosecretosome (Fig. 4), we find the calcium channel; 
synaptotagmin, a calcium sensor [28] which has been 
directly implicated in the control of fast transmitter 
release [25]; and both syntaxin and the neurexins, mole- 
cules which qualify as potential acceptor sites for synap- 
tic vesicles [5,8,11,17]. The fast time course of transmit- 
ter release implies the predocking of ssvs at the site of 
the calcium influx that triggers the release process. 
Therefore, the in vitro interactions described here pro- 
vide a seductive working model of potential compo- 
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nents invo lved in the organ izat ion  o f  the active zone. 
Fur ther  approaches  will be required to establ ish how 
these molecules  and the interact ions they show with 
each other  contro l  and/or  modu la te  neurot ransmi t te r  
release. 
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